132 related articles for article (PubMed ID: 19567472)
1. PML-IV functions as a negative regulator of telomerase by interacting with TERT.
Oh W; Ghim J; Lee EW; Yang MR; Kim ET; Ahn JH; Song J
J Cell Sci; 2009 Aug; 122(Pt 15):2613-22. PubMed ID: 19567472
[TBL] [Abstract][Full Text] [Related]
2. Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.
Xue Y; Li L; Zhang D; Wu K; Guo P; Zeng J; Wang X; He D
Oncol Rep; 2010 Dec; 24(6):1551-9. PubMed ID: 21042751
[TBL] [Abstract][Full Text] [Related]
3. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors suppress IFNalpha-induced up-regulation of promyelocytic leukemia protein.
Vlasáková J; Nováková Z; Rossmeislová L; Kahle M; Hozák P; Hodny Z
Blood; 2007 Feb; 109(4):1373-80. PubMed ID: 17062732
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.
Kuwayama K; Matsuzaki K; Mizobuchi Y; Mure H; Kitazato KT; Kageji T; Nakao M; Nagahiro S
Neuro Oncol; 2009 Apr; 11(2):132-41. PubMed ID: 18812519
[TBL] [Abstract][Full Text] [Related]
6. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
Yeager TR; Neumann AA; Englezou A; Huschtscha LI; Noble JR; Reddel RR
Cancer Res; 1999 Sep; 59(17):4175-9. PubMed ID: 10485449
[TBL] [Abstract][Full Text] [Related]
7. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.
Fuchsová B; Novák P; Kafková J; Hozák P
J Cell Biol; 2002 Aug; 158(3):463-73. PubMed ID: 12163469
[TBL] [Abstract][Full Text] [Related]
8. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
9. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
10. Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines.
French JD; Dunn J; Smart CE; Manning N; Brown MA
Genes Chromosomes Cancer; 2006 Mar; 45(3):277-89. PubMed ID: 16283620
[TBL] [Abstract][Full Text] [Related]
11. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.
Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; Londoño-Vallejo A
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459
[TBL] [Abstract][Full Text] [Related]
12. HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
Zhu Z; Tran H; Mathahs MM; Moninger TO; Schmidt WN
PLoS One; 2017; 12(1):e0166853. PubMed ID: 28056029
[TBL] [Abstract][Full Text] [Related]
13. Myocardin a enhances telomerase activities in adipose tissue mesenchymal cells and embryonic stem cells undergoing cardiovascular myogenic differentiation.
Madonna R; Willerson JT; Geng YJ
Stem Cells; 2008 Jan; 26(1):202-11. PubMed ID: 17916802
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
15. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
Cheng X; Liu Y; Chu H; Kao HY
J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
[TBL] [Abstract][Full Text] [Related]
16. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
Ito T; Watanabe H; Yamamichi N; Kondo S; Tando T; Haraguchi T; Mizutani T; Sakurai K; Fujita S; Izumi T; Isobe T; Iba H
Biochem J; 2008 Apr; 411(1):201-9. PubMed ID: 18042045
[TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of the catalytic subunit of telomerase in normal and cataractous canine lens epithelial cells.
Colitz CM; Barden CA; Lu P; Chandler HL
Mol Vis; 2006 Sep; 12():1067-76. PubMed ID: 17093391
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia protein is required for gain of function by mutant p53.
Haupt S; di Agostino S; Mizrahi I; Alsheich-Bartok O; Voorhoeve M; Damalas A; Blandino G; Haupt Y
Cancer Res; 2009 Jun; 69(11):4818-26. PubMed ID: 19487292
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid attenuates promyelocytic leukemia protein-induced cell death in breast cancer cells by activation of the ubiquitin-proteasome pathway.
Son SH; Yu E; Ahn Y; Choi EK; Lee H; Choi J
Cancer Lett; 2007 Mar; 247(2):213-23. PubMed ID: 16740359
[TBL] [Abstract][Full Text] [Related]
20. Activation of telomerase by human cytomegalovirus.
Strååt K; Liu C; Rahbar A; Zhu Q; Liu L; Wolmer-Solberg N; Lou F; Liu Z; Shen J; Jia J; Kyo S; Björkholm M; Sjöberg J; Söderberg-Nauclér C; Xu D
J Natl Cancer Inst; 2009 Apr; 101(7):488-97. PubMed ID: 19318640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
